Description

Intuitive Surgical’s Next Big Catalyst — da Vinci 5, Ion & Single-Port Growth Converge!

Intuitive Surgical reported a solid second quarter in 2026 with several positive operational and financial indicators, alongside some market-specific challenges reflective of broader healthcare dynamics. The company saw total procedure volume increase by 16%, including a 15% growth in da Vinci system procedures and a 36% rise in Ion platform procedures. The global installed base expanded by 12% for da Vinci systems and 21% for Ion systems, totaling nearly 13,000 systems worldwide by quarter-end. Growth was driven primarily by strong adoption in general surgery and after-hours procedures in the United States and double-digit percentage increases across Europe, Asia, and other international markets. Despite these gains, growth in the U.S. moderated compared to earlier periods, largely attributed to shifts in patient coverage and premium subsidy changes under the Affordable Care Act, affecting timing and deferral of some procedures, particularly benign or elective surgeries.